| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.23 | 0.0002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |